Log in to save to my catalogue

Methylation-based smoking signatures in blood and tissue samples for the prediction of self-reported...

Methylation-based smoking signatures in blood and tissue samples for the prediction of self-reported...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12225191

Methylation-based smoking signatures in blood and tissue samples for the prediction of self-reported smoking status and mortality in patients with colorectal cancer

About this item

Full title

Methylation-based smoking signatures in blood and tissue samples for the prediction of self-reported smoking status and mortality in patients with colorectal cancer

Publisher

Germany: BioMed Central Ltd

Journal title

Clinical epigenetics, 2025-07, Vol.17 (1), p.113, Article 113

Language

English

Formats

Publication information

Publisher

Germany: BioMed Central Ltd

More information

Scope and Contents

Contents

Smoking is a well-established risk factor for colorectal cancer (CRC) development. However, the reliability of DNA methylation-based smoking signatures in predicting smoking status and their prognostic value in CRC remain unclear, particularly across different biological sample types.
Five previously validated methylation-based smoking signature...

Alternative Titles

Full title

Methylation-based smoking signatures in blood and tissue samples for the prediction of self-reported smoking status and mortality in patients with colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12225191

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12225191

Other Identifiers

ISSN

1868-7083,1868-7075

E-ISSN

1868-7083

DOI

10.1186/s13148-025-01918-9

How to access this item